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Abstract: The functional FABP2 Ala54Thr polymorphism (rs1799883) is strongly associated with lipid
and carbohydrate metabolism, although the function of its potential modifying effect on training-
induced changes in obesity-related parameters is still unknown. The aim of the present study was
to investigate the influence of the Ala54Thr polymorphism on post-training changes of selected
body mass and body composition measurements, as well as with biochemical parameters of energy
metabolism. Accordingly, alleles and genotypes distribution in a group of 168 young, nonobese
Caucasian women measured for chosen body composition parameters, lipid profile, and glucose
levels before and after the completion of a 12-week aerobic training program were studied. Although
the obtained results showed changes in body mass, BMI, FM, %FM, FFM, TBW, HDL-C, and glucose
levels during the training program, none of the examined parameters changed significantly across
the FABP2 genotypes. Instead, we found a main effect of genotype on BMI (p = 0.033), with carriers
of the Thr54 allele having a higher BMI during the whole study period compared with the Ala54
carriers. We confirm that the FABP2 Ala54Thr polymorphism may help identify women at risk for
overweight and obesity. However, we did not notice evidence of an interaction between physical
activity and the Ala54Thr polymorphism on the examined parameters.
Keywords: sport genetics; physical activity; FABP2 gene; polymorphism; body composition; lipid
profile; adaptation
1. Introduction
Regular physical activity confers many benefits to human health and is a key element
of total everyday energy expenditure; as such, it assists in improving body composition and
reducing excess body weight. Accordingly, the promotion of exercise, and related exercise
training programs, is a key step towards reducing the ever-increasing worldwide epidemic
of obesity [1,2]. Li et al., (2010) revealed that physical activity is related with around a 40%
reduction in genetic predisposition to overweight and obesity, as assessed by the number
of risk alleles carried for genome-wide association studies (GWAS) identified loci [3]. An
understanding of the role the various genetic variants exert on the range of the body’s
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adaptive response to training will support prediction of the consequences of the performed
exercises, making training programs more efficient and safer [2]. Over 1000 chromosomal
regions and genes have been shown to be involved in body weight and energy metabolism
control [4,5]. One of the most promising candidate genetic markers is fatty acid binding
protein 2 (FABP2), the gene encoding for an intracellular protein which is a member of the
FABPs superfamily, acting to bind hydrophobic ligands [6].
FABP2 is a small protein (15 kDa) expressed at high levels in the columnar absorptive
epithelial cells of the villi in the intestine (enterocytes). FABP2 includes a single ligand
binding site that shows a strong affinity for saturated and unsaturated long-chain fatty acids
and is involved in the synthesis of triglyceride-rich lipoproteins. This protein participates
in the absorption, intracellular transport, and metabolism of dietary fatty acids and their
acyl-CoA esters in small intestine [7–9]. There is experimental evidence that high levels of
FABP2, expressed in a differentiated enterocyte model, may inhibit fatty acid incorporation
by a currently-undefined mechanism [10].
In humans, the FABP2 gene is located in the long arm of chromosome 4 (4q28-4q31)
and consists of 4 exons separated by 3 introns [11]. In 1995, Baier et al. described a common
nucleotide transition from guanine (G) to adenine (A) at codon 54 in exon 2 of the FABP2
gene that results in an alanine (Ala) to a threonine (Thr) change (Ala54Thr; rs1799883) [7].
Many, but not all studies, have shown this amino acid substitution to be a functional
mutation which results in physiological consequences at the molecular, cellular, and organ
levels [7,9,12].
Although numerous investigators have shown that carriers of the Thr54 variant
of FABP2 have nearly twice the affinity for long-chain fatty acids compared with those
with the Ala54 allele, supporting the potential function of the Ala54Thr polymorphism
in the etiology of human obesity, others have not [7,13–16]. A sexual dimorphism with
regard to body mass index (BMI) was shown for the Ala54Thr polymorphism [13,14]. The
inconsistency of these results may be explained by the fact that in most of the previous
studies on physical activity and/or diet composition were usually not taken into account.
In light of the evidence that the missense variation is strongly associated with lipid
and carbohydrate metabolism, FABP2 is an extensively studied candidate gene related
to metabolic disorders including obesity, diabetes, and metabolic syndrome [7,9,14–17].
However, it is unclear whether physical activity levels affect the relationship between the
obesity-related traits and genetic variation in FABP2. Accordingly, the aim of the present
study was to investigate the influence of the Ala54Thr polymorphism on post-training
changes of selected body mass and body composition measurements, as well as with
biochemical parameters of energy metabolism. We studied the alleles and the genotype
distribution in women engaged in a 12-week aerobic training program, searching for
any associations.
2. Materials and Methods
2.1. Ethics Statement
The investigation protocols were performed in accordance with the rules of the World
Medical Association Declaration of Helsinki, as well as ethical standards in sport and
exercise science research. The procedures were accepted by the Ethics Committee of
the Regional Medical Chamber in Szczecin (no. 09/KB/IV/2011 and 01/KB/VI/2017).
Participants received a written information sheet concerning the study purpose, procedures
used, benefits and risks, as well as a consent form. The experimental protocols were
conducted according to the Strengthening the Reporting of Genetic Association studies
(STREGA) Statement.
2.2. Participants
One hundred sixty eight Polish Caucasian women (age: 21 ± 1 years; body mass:
61 ± 2 kg; body height: 168 ± 2 cm) were included in the study. The following inclusion
criteria were considered: low level of physical activity self-reported by each participant
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with the use of the Global Physical Activity Questionnaire (according to the World Health
Organization in the Polish adaptation), no metabolic, neuromuscular or musculoskeletal
disorders, refrained from using supplements or medications, nonsmokers. The participants
took part in a dietary program and were asked to keep a balanced diet based on their
individual dietary plan which was established during a nutritional appointment including
a recommendation and a prescription of an adequate diet fitted for individual energy need
and nutritional status, as well as a food replacement list. The following average daily
macronutrient ratio was recommended (expressed as a percentage of total calories): 45–65%
from carbohydrates, 10–20% from protein, and 20–35% from fat (with a simultaneous focus
on decreasing the intake of saturated fats and increasing the intake of unsaturated fats). A
daily cholesterol intake was recommended to be lower than 300 mg, while the intake of
dietary fiber was recommended to be higher than 25 g. All participants kept a daily “diet
diary” in which they included everything they ate and drank during the program. The
quantity and quality of meals were assessed during diet consultations, which were carried
out every week.
2.3. Body Composition Measurements
All participants were measured for selected body mass and body composition param-
eters before and after the 12-week training period. The variables were assessed using the
bioimpedance method, using a Tanita TBF 300M electronic scale (Arlington Heights, IL,
USA). The following parameters were measured with the electronic scale: total body mass
(kg), BMI (kg/m2), fat mass (FM, kg), fat mass percentage (%FM, %), fat free mass (FFM,
kg), and total body water (TBW, kg) [18].
2.4. Biochemical and Hematological Analyses
Fasting blood samples were obtained from the elbow vein in the morning, before the
aerobic fitness training program, and after the 36th training unit, which occurred during the
12th week of the program. The biochemical and hematological analyses were performed
as described earlier, immediately after blood collection [18]. The parameters received
using the Random Access Automatic Biochemical Analyzer for Clinical Chemistry and
Turbidimetry A15 (BioSystems S.A., Barcelona, Spain) were: glucose (mg/dL), triglycerides
(TGL, mg/dL), total cholesterol (TC, mg/dL), high density lipoprotein cholesterol (HDL-C,
mg/dL), and low density lipoprotein cholesterol (LDL-C, mg/dL).
2.5. Training Phase
A week-long familiarization stage preceded the proper training stage. During this
stage, participants exercised 3 times a week for 30 min at an intensity of about fifty percent
of their maximum heart rate (HRmax). After the familiarization stage, the main training
program started. Each training unit consisted of the following stages: warm-up routine
(10 min), main aerobic routine (43 min), stretching and breathing exercises (7 min). The
major aerobic routine consisted of a combination of 2 alternating styles—low and high
impact, as presented by Leońska-Duniec et al. [18].
2.6. Genetic Analyses
GenElute Mammalian Genomic DNA Miniprep Kit (Sigma, Steinheim, Germany) was
used for the extraction of DNA from the buccal cells in accordance with the manufacturer’s
procedure. An allelic discrimination assay on a C1000 Touch Thermal Cycler (Bio-Rad, Feld-
kirchen, Germany) instrument with TaqMan probes was used to genotype all samples in
duplicate. TaqMan® Pre-Designed SNP Genotyping Assays (Applied Biosystems, Waltham,
MA, USA) (assay ID: C____761961_10), including primers and fluorescently labelled (FAM
and VIC) minor groove binder (MGB) probes were used in order to discriminate the FABP2
Ala54Thr alleles.
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2.7. Statistical Analyses
Gene counting was used to determine allele frequencies. A chi-square test was used
to test the Hardy–Weinberg equilibrium. 2 × 2 mixed-design ANOVA tests were used to
test the influence of the Ala54Thr polymorphism of the FABP2 gene on training response.
In addition, the Kolmogorov–Smirnov test was used to check for data normality, as well as
the post hoc Fisher’s least significant difference (LSD) test. The models of inheritance, i.e.,
codominant, dominant, recessive and overdominant were constructed assuming a minor
allele as the risk allele. The level of statistical significance was set at p < 0.05.
3. Results
Genotype frequencies of the FABP2 polymorphism: Ala54/Ala54—80 (47.62%), Ala54/
Thr54—80 (47.62%) and Thr54/Thr54—8 (4.76%) deviated significantly from the Hardy–
Weinberg expectations (χ2 = 4.67, p = 0.031). The selected body composition and metabolic
parameters before the 12-week training period initialization are presented in Table 1.
Table 1. Body composition and metabolic parameters before training program initialization.
Parameter Pre
body mass (kg) 59.2 (55.2–65.5)
BMI (kg/m2) 21.3 (19.9–22.9)
%FM (%) 24.3 (20.2–28.1)
FM (kg) 14.5 (11.2–17.4)
FFM (kg) 45.4 (43.6–47.6)
TBW (kg) 33.2 (31.8–35.0)
TC (mg/dL) 167.0 (150.5–184.5)
TGL (mg/dL) 73.0 (60.0–92.0)
HDL-C (mg/dL) 64.4 (55.0–73.9)
LDL-C (mg/dL) 87.3 (71.2–103.9)
Glucose (mg/dL) 80.0 (71.0–85.0)
Median (lower quartile-upper quartile).
Pre- and post-training body composition and metabolic parameters with respect to
the FABP2 genotype are presented in Table 2. Most parameters (body mass, BMI, %FM, FM,
FFM, TBW, HDL-C, and glucose) changed significantly during the intervention (main effect
of training), however, the training response did not tend to be modulated by genotype
(non-significant genotype × training interactions).
Table 2. The FABP2 genotypes and response to training (2-way repeated measures ANOVA).
Parameter Ala54/Ala54(n = 80)
Ala54/Th54r + Thr54/Thr54
(n = 88) Genotype Training
Genotype ×
Training Interaction
Pre Post Pre Post p p p









(19.4–24.2) 0.033 <0.0001 0.954
%FM (%) 23.3 ± 5.4 21.7 ± 5.7 24.5 ± 5.4 23.4 ± 5.4 0.079 <0.0001 0.128
FM (kg) 14.3 ± 5.1 13.2 ± 5.2 15.4 ± 5.0 14.5 ± 4.9 0.124 <0.0001 0.379
FFM (kg) 45.5 ± 3.2 46.0 ± 3.2 45.9 ± 3.2 46.2 ± 3.3 0.465 0.00002 0.235
TBW (kg) 33.3 ± 2.8 33.8 ± 2.4 33.6 ± 2.4 33.8 ± 2.4 0.589 0.002 0.318
TC (mg/dL) 170 ± 26 166 ± 26 170 ± 23 171 ± 28 0.514 0.380 0.068






(58.4–107.3) 0.719 0.175 0.847
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Table 2. Cont.
Parameter Ala54/Ala54(n = 80)
Ala54/Th54r + Thr54/Thr54
(n = 88) Genotype Training
Genotype ×
Training Interaction
Pre Post Pre Post p p p
HDL-C (mg/dL) 63.7 ± 12.1 59.2 ± 12.9 66.6 ± 14.5 63.3 ± 13.9 0.063 0.000005 0.436
LDL-C (mg/dL) 90.2 ± 23.3 89.9 ± 23.5 87.2 ± 20.5 91.3 ± 23.7 0.798 0.218 0.147
Glucose(mg/dL) 78.1 ± 10.2 74.9 ± 9.7 78.3 ± 9.4 76.2 ± 10.5 0.579 0.001 0.498
Mean ± SD; * geometric mean (antiloged mean of the log data), in brackets-antilog of the log mean + log SD and log mean-log SD;
BMI—body mass index; %FM—fat mass percentage; FM—fat mass; FFM—fat free mass; TBW—total body water; TC—total cholesterol;
TGL—triglycerides; HDL-C—high density lipoprotein cholesterol, LDL-C—low density lipoprotein cholesterol; the level of statistical
significance was set at p < 0.05.
Instead, we found a main effect of genotype on BMI (F(1,166) = 4.63, p = 0.033,
η2 = 0.027) only under the dominant model. The Fisher’s least significant difference test
was significant at baseline (Ala54/Thr54 + Thr54/Thr54, 21.9 (19.6–24.4) vs Ala54/Ala54,
21.1 (18.9–23.5); p = 0.023) and at the end (Ala54/Thr54 + Thr54/Thr54, 21.6 (19.4–24.2)
vs Ala54/Ala54, 20.9 (18.8–23.2); p = 0.033). No significant associations were found when
other underlying genetic models were assumed.
4. Discussion
A number of papers focusing on physical activity behavior and exercise intolerance,
cardiorespiratory fitness and endurance performance, muscular strength and power, body
weight and adiposity, lipid and lipoprotein metabolism, glucose and insulin metabolism,
as well as hemodynamic traits, have revealed genetic markers influencing the functional
response of human body to regular physical activities [2,19]. One of the proposed genes
associated with obesity, and with potential significance on the body’s adaptive response to
training in healthy individuals, is FABP2.
Although the present study of Caucasian women demonstrated changes of many
selected body mass measurements and biochemical parameters of energy metabolism, such
as body mass, BMI, FM, FFM, %FM, TBW, HDL-C, and glucose levels during the 12-week
training program, none of the selected parameters changed significantly across FABP2
genotypes (genotype × training interaction). Another important finding of the data is the
identification of a statistically significant association between BMI and FABP2 genotype.
Carriers of the Thr54 variant of FABP2 had a higher BMI during the entire study period
compared with the Ala54 carriers, suggesting that the Thr54 allele is a risk allele involved
in excess body weight in Caucasian females. Some genotype effects may be evident only
in Thr54/Thr54 homozygotes. Unfortunately, we had insufficient Thr54 homozygotes to
analyze separately, which may affect our results.
Many studies have generally focused on the role of the intestinal FABP2 in the absorp-
tion, transport, and metabolism of saturated and unsaturated long-chain fatty acids [7–9].
Darimont et al., (2000) showed that a high level of FABP2 expressed in a differentiated ente-
rocyte model inhibits incorporation of fatty acid, but the mechanism is still unknown [10].
Additionally, animal model experiments revealed that Fabp2 null (Fabpi-/-) mice show
changes in body weight and are hyperinsulinemic. Male Fabpi-/- mice had higher plasma
TGL and body weight regardless of the fat content in their diet. In contrast, female Fabpi-/-
mice gained less weight in response to a high-fat diet. The studies on Fabpi-/- mice and
human Ala54Thr polymorphism suggest that FABP2 is not a direct part of fatty acid ab-
sorption but may act as a lipid-sensing component of energy homeostasis that modifies
body weight gain in a gender-dependent fashion [20]. However, the exact physiological
role of the protein has never been revealed clearly.
While the excess absorption of saturated and unsaturated long-chain fatty acids
during sedentary state is considered as a risk factor for obesity, in trained participants
this condition may give additional advantage for endurance performance, as suggested
by Nasibulina et al. [21], who demonstrated that Thr54 allele frequency was significantly
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higher in elite Russian endurance (50.0%) and combat (46.2%) athletes compared to controls
(32.2%). This is in line with a previous study showing that increased availability of free
fatty acids, following a high-fat diet, may provide for increased oxidative potential as
evidenced by a growth in VO2max and a decreased running time in trained runners [22].
The possible relationship between the Ala54Thr polymorphism and BMI, a measure
widely accepted as an index for identifying human overweight and obesity, have been
widely described; however, the obtained results are so far conflicting and inconclusive [23].
Fisher et al., (2006) showed that German women with the Thr54 allele have higher BMI
and suggested that the Thr54 allele is an effect-modifier for BMI in females [13]. These
results are supported by Khattab et al., (2017) who indicated that both the Ala54/Thr54
heterozygotes and carriers of the rare Thr54/Thr54 genotype had significantly higher BMI
among an Egyptian population [24]. The presence of the Thr54/Thr54 homozygotes was
also significantly associated with obesity in a study of 430 Caucasians of Greek ethnic
origin. Here, Tavridou et al., (2009) suggested that the FABP2 Ala54Thr polymorphism
may help identify Caucasian participants at risk for obesity [25]. Additionally, our study
confirmed this association in Polish women. Conversely, several studies do not support
the relationship between the FABP2 Ala54Thr polymorphism and BMI. A meta-analysis
including 27 studies with 10 974 participants revealed a lack of association between the
polymorphism and BMI across populations. Zhao et al., (2011) also analyzed subgroups
stratified by ethnicity, gender, health condition but again detected no statistically significant
differences [26].
Numerous investigators have also looked for associations between the specific FABP2
genotype and a variety of biochemical parameters [7,16,24,27–29]. Previously, Baier et al.,
(1995) revealed that the Thr54-containing protein may increase absorption and/or pro-
cessing of fatty acids in the intestine, therefore increasing fat oxidation. This has been
demonstrated to decrease insulin action, resulting in insulinemia, along with increased
LDL-C, TC, and TGL [7]. In a meta-analysis of 30 studies with 14,401 participants, the
Thr54/Thr54 genotype was strongly associated with increased TC and LDL-C levels, as
well as decreased HDL-C levels [16]. Khattab et al., (2017) confirmed that carriers of
the Thr54/Thr54 genotype had decreased HDL-C concentrations [24]. Conversely, some
studies have reported that lipid profiles do not significantly differ based on FABP2 geno-
type [27,28]. A study performed on the Finnish population indicated that fasting serum
insulin, glucose, lipids and lipoprotein concentrations, BMR, respiratory quotient, glucose
and lipid oxidation levels did not vary among the genotypes [28]. Similar to our results,
Kops et al., (2017) described that Thr54 allele carriers showed higher BMI, but with similar
lipid profiles in both carriers and noncarriers [29]. A study performed on 111 nondiabetic
obese participants following an enriched polyunsaturated fatty acids hypocaloric diet,
De Luis et al., (2012) reported no differences in basal values of insulin, glucose, TGL, or
LDL-C between genotypes. However, participants with the Thr54 allele demonstrated
an improvement in TC, LDL-C, and insulin levels following weight loss [27]. Similarly,
Martinez-Lopez et al., (2013) showed that dietary modification through limitation of satu-
rated fat intake significantly decreases BMI, waist-to-hip ratio, waist circumference, and
CRP in Thr54 allele carriers [17]. We did not confirm the association between the specific
FABP2 genotype and different post-training changes of selected body composition mea-
surements, lipid profile, and glucose levels. Our findings are consistent with Han (2013),
who described that 12-week regular aerobic exercise training may beneficially prevent
obesity-related traits; however, none of the examined parameters changed significantly
across the FABP2 genotypes [15]. Additionally, fasting blood lipids, such as TC, HDL-C,
and TGL levels, were not affected significantly by the related effects of the FABP2 Ala54Thr
genotype and cardiorespiratory fitness in 837 Japanese participants [30].
The gender-specific effects of the functional influence of the FABP2 Ala54Thr poly-
morphism may explain these conflicting results [13,31]. Fisher et al., (2006) reported an
important association of the polymorphism with higher BMI and decreased risk of type 2
diabetes only in German female participants [13]. Nakanishi et al., (2004) described that,
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amongst non-obese women, BMI was higher in the Thr54 carriers [31], which is consistent
with our findings. Unfortunately, the presented study included only women, because men
did not report to our experiment, and, as a result, we could not examine these depen-
dences. Variation in ethnicities, physical activity, diet, methodology, as well as different
statistical approaches in respect to risk ratio estimation, such as pooling homozygous and
heterozygous individuals, may also affect results. Additionally, dietary lipid intake is a
key determinant of blood cholesterol levels; therefore, differences in lipid intake among
different cultures may partly explain the inconclusive results obtained in the mentioned
studies [30].
5. Conclusions
Our results confirm that the FABP2 Ala54Thr polymorphism may help identify Cau-
casian participants at risk for obesity. Carriers of the Thr54 variant had a higher BMI during
the entire study period compared with the Ala54 carriers, suggesting that the Thr54 allele
is a risk allele involved in body weight excess in Caucasian females. However, whilst
many body composition parameters, lipid profile, and glucose levels changed significantly
during the 12-week training program, we did not find evidence of the association between
the FABP2 Ala54Thr polymorphism and physical activity on the examined parameters.
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